This information is intended for Colorado Prescribers
HB 19-1131
Sanofi Singular Form with QR Code
Last Update: January 15, 2024
Diabetes Products
Last Update: January 21, 2025
Vaccines
Last Update: January 21, 2025
ALDURAZYME® (laronidase)
Last Update: January 3, 2025
ALPROLIX® [Coagulation factor IX (recombinant), Fc fusion protein]
Last Update: January 3, 2025
ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]
Last Update: January 3, 2025
CABLIVI® (caplacizumab-yhdp)
Last Update: January 3, 2025
CERDELGA® (eliglustat) capsules, for oral use
Last Update: January 3, 2025
Cerezyme® (imiglucerase) for injection
Last Update: January 3, 2025
DUPIXENT® (dupilumab) Injection
Last Update: January 3, 2025
ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]
Last Update: January 3, 2025
FABRAZYME® (agalsidase beta) for injection, for intravenous use
Last Update: January 3, 2025
KEVZARA® (sarilumab)
Last Update: January 3, 2025
LEMTRADA® (alemtuzumab)
Last Update: January 3, 2025
LUMIZYME® (alglucosidase alfa)
Last Update: January 3, 2025
MULTAQ® (dronedarone)
Last Update: January 22, 2025
NEXVIAZYME® (avalglucosidase alfa-ngpt) for injection, for intravenous use
Last Update: January 3, 2025
REZUROCK® (belumosudil) tablets
Last Update: January 3, 2025
SARCLISA® (isatuximab-irfc) injection
Last Update: January 3, 2025
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]
Last Update: January 3, 2025
THYROGEN® (thyrotropin alfa for injection)
Last Update: January 15, 2025
TZIELD® (teplizumab-mzwv)
Last Update: January 3, 2025
XENPOZYME® (olipudase alfa-rpcp) for injection, for intravenous use
Last Update: January 3, 2025
House Bill 19-1131. Published by the General Assembly of the State of Colorado
Please See Full Prescribing Information, including Boxed Warning, for Aldurazyme, Cerezyme, Fabrazyme, Kevzara, Lemtrada, Lumizyme, Multaq, Nexviazyme, Thymoglobulin , Xenpozyme
MAT-US-2007971-v12.0-02/2025